Carefully consider the potential benefits and risks of MOBIC and other treatment options before deciding to use MOBIC. Use the lowest effective dosage for the shortest duration consistent with individual patient treatment goals [see  WARNINGS AND PRECAUTIONS].
After observing the response to initial therapy with MOBIC, adjust the dose to suit an individual patient's needs.
In adults, the maximum recommended daily oral dose of MOBIC is 15 mg regardless of formulation. In patients with hemodialysis, a maximum daily dosage of 7.5 mg is recommended [see Use in Specific Populations and CLINICAL PHARMACOLOGY].
MOBIC may be taken without regard to timing of meals.
For the relief of the signs and symptoms of osteoarthritis the recommended starting and maintenance oral dose of MOBIC is 7.5 mg once daily. Some patients may receive additional benefit by increasing the dose to 15 mg once daily.
For the relief of the signs and symptoms of rheumatoid arthritis, the recommended starting and maintenance oral dose of MOBIC is 7.5 mg once daily. Some patients may receive additional benefit by increasing the dose to 15 mg once daily.
For the treatment of juvenile rheumatoid arthritis, the recommended oral dose of MOBIC is 7.5 mg once daily in children who weigh  â‰¥ 60 kg. There was no additional benefit demonstrated by increasing the dose above 7.5 mg in clinical trials.
MOBIC tablets should not be used in children who weigh  < 60 kg.
The use of MOBIC in subjects with severe renal impairment is not recommended.
In patients on hemodialysis, the maximum dosage of MOBIC is 7.5 mg per day [see CLINICAL PHARMACOLOGY].
MOBIC Tablets have not shown equivalent systemic exposure to other approved formulations of oral meloxicam. Therefore, MOBIC Tablets are not interchangeable with other formulations of oral meloxicam product even if the total milligram strength is the same. Do not substitute similar dose strengths of MOBIC Tablets with other formulations of oral meloxicam product.
